FDA Inspection 1246994 — Tianjin Kingyork Pharmaceuticals Co., Ltd
The FDA completed an inspection of Tianjin Kingyork Pharmaceuticals Co., Ltd on Jul 26, 2024 in Tianjin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tianjin (China)